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Background
Intravenous immunoglobulin (IVIg) has potent immune-
modulating properties. In OVA-challenged mice, we
demonstrated that IVIg markedly attenuates airway
hyperresponsiveness (AHR) and abrogates airways
inflammation, accompanied by substantial induction of
antigen-specific Foxp3
+ Treg from non-Treg precursors.
Methods
Mice were sensitized (i.n.) with OVA and then received
IVIg or sialic acid enriched IVIg (SA-IVIg) fragments
(i.p.), and then underwent challenge (i.n.). The induction
of CD4
+CD25
+Foxp3
+Treg was determined by flow-
cytometry. AHR was measured, using a flexiVent small
animal ventilator. Phenotypic properties of dendritic
cells (DC) from various experimental groups were
assessed by flow-cytometry. Expression of DCIR on DC
was evaluated by flowcytometry and ICC. Adoptive
transfer of DC was carried out to show the tolerogenic
activity of IVIg-primed DC.
Results
IVIg and the SA-IVIg fraction induced Treg and abrogated
AHR in OVA-challenged mice comparably. It followed by
tolerogenic predisposition of DC (decrease of CD80/CD86
expression and IFN-g production and increased level of
IL-10). Adoptive transfer of DC from IVIg treated mice to
OVA-challenged WT syngeneic mice has the similar anti-
inflammatory activity of IVIg/SA-IVIg. Expression of
DCIR (Inhibitory C-type lectin receptors) on DC of IVIg
and SA-IVIg treated mice increased significantly.
Conclusions
IVIg induces Treg likely via conferring tolerogenic activ-
ities to DC. This mechanism is dependent on sialylated
fraction of IVIg. DCIR is an inhibitory C-type lectin recep-
tor that can be targeted by SA-IVIg and induce an inhibi-
tory signal into the ligated cells. More dissection is
required to confirming the role of DCIR in this model.
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